|
GB8621095D0
(en)
*
|
1986-09-01 |
1986-10-08 |
Ici Plc |
Electrostatic spraying apparatus
|
|
US5042723A
(en)
*
|
1986-09-01 |
1991-08-27 |
Imperial Chemical Industries Plc |
Electrostatic spraying apparatus
|
|
EP0394222B1
(de)
*
|
1987-09-22 |
1992-02-26 |
Imperial Chemical Industries Plc |
Elektrostatische sprühvorrichtung
|
|
JP2587298B2
(ja)
*
|
1989-10-30 |
1997-03-05 |
オーベクス 株式会社 |
液体揮散装置
|
|
US5178330A
(en)
*
|
1991-05-17 |
1993-01-12 |
Ransburg Corporation |
Electrostatic high voltage, low pressure paint spray gun
|
|
US5605605A
(en)
*
|
1992-03-02 |
1997-02-25 |
Imperial Chemical Industries Plc |
Process for treating and sizing paper substrates
|
|
US5326598A
(en)
*
|
1992-10-02 |
1994-07-05 |
Minnesota Mining And Manufacturing Company |
Electrospray coating apparatus and process utilizing precise control of filament and mist generation
|
|
US5402945A
(en)
*
|
1993-01-22 |
1995-04-04 |
Gervan Company International |
Method for spraying plants and apparatus for its practice
|
|
US6703050B1
(en)
*
|
1998-09-04 |
2004-03-09 |
The Regents Of The University Of Michigan |
Methods and compositions for the prevention or treatment of cancer
|
|
US6397838B1
(en)
*
|
1998-12-23 |
2002-06-04 |
Battelle Pulmonary Therapeutics, Inc. |
Pulmonary aerosol delivery device and method
|
|
US6368562B1
(en)
|
1999-04-16 |
2002-04-09 |
Orchid Biosciences, Inc. |
Liquid transportation system for microfluidic device
|
|
IL146034A0
(en)
|
1999-04-23 |
2002-07-25 |
Battelle Memorial Institute |
High mass transfer electrosprayer
|
|
US6485690B1
(en)
|
1999-05-27 |
2002-11-26 |
Orchid Biosciences, Inc. |
Multiple fluid sample processor and system
|
|
US6339107B1
(en)
|
2000-08-02 |
2002-01-15 |
Syntex (U.S.A.) Llc |
Methods for treatment of Emphysema using 13-cis retinoic acid
|
|
EP1935869A1
(de)
|
2000-10-02 |
2008-06-25 |
F. Hoffmann-La Roche Ag |
Retinoide zur Behandlung von Emphysem
|
|
US20030181416A1
(en)
*
|
2002-01-10 |
2003-09-25 |
Comper Wayne D. |
Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
|
|
US20040009953A1
(en)
*
|
2002-01-10 |
2004-01-15 |
Comper Wayne D. |
Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
|
|
GEP20074270B
(en)
|
2002-07-23 |
2007-12-25 |
Univ Michigan |
Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
|
|
US7189865B2
(en)
*
|
2002-07-23 |
2007-03-13 |
Attenuon, Llc |
Thiomolybdate analogues and uses thereof
|
|
EP1551386A4
(de)
*
|
2002-09-27 |
2009-03-25 |
Bioenvision Inc |
Verfahren und zusammensetzungen zur behandlung von lupus mit clofarabin
|
|
WO2004029025A2
(en)
*
|
2002-09-27 |
2004-04-08 |
Bioenvision, Inc. |
Methods and compositions for the treatment of autoimmune disorders using clofarabine
|
|
WO2004032864A2
(en)
*
|
2002-10-07 |
2004-04-22 |
Radiorx, Inc. |
X-nitro compounds, pharmaceutical compositions thereof and uses therof
|
|
MXPA05005545A
(es)
*
|
2002-11-25 |
2005-10-18 |
Attenuon Llc |
Peptidos que se dirigen a celulas tomurales y endoteliales, composiciones y usos de los mismos.
|
|
ZA200504940B
(en)
*
|
2003-01-28 |
2006-09-27 |
Xenoport Inc |
Amino acid derived prodrugs of propofol, compositions and uses thereof
|
|
JP4713465B2
(ja)
|
2003-03-12 |
2011-06-29 |
セルジーン コーポレイション |
7−アミド−イソインドリル化合物およびその薬学的使用
|
|
HUE047569T2
(hu)
|
2003-04-11 |
2020-04-28 |
Ptc Therapeutics Inc |
1,2,4-oxadiazol-benzoesav vegyület és nonszensz szupresszióra történõ alkalmazása
|
|
JP2007516234A
(ja)
*
|
2003-05-27 |
2007-06-21 |
アテニュオン,リミティド ライアビリティー カンパニー |
チオタングステン酸(塩)アナログ及びその使用
|
|
US20050009782A1
(en)
*
|
2003-07-09 |
2005-01-13 |
Comper Wayne D. |
Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
|
|
US7230003B2
(en)
*
|
2003-09-09 |
2007-06-12 |
Xenoport, Inc. |
Aromatic prodrugs of propofol, compositions and uses thereof
|
|
US20060004043A1
(en)
|
2003-11-19 |
2006-01-05 |
Bhagwat Shripad S |
Indazole compounds and methods of use thereof
|
|
WO2005082382A1
(en)
*
|
2004-02-23 |
2005-09-09 |
Attenuon Llc |
Formulations of thiomolybdate or thiotungstate compounds and uses thereof
|
|
DE602005010270D1
(de)
*
|
2004-07-12 |
2008-11-20 |
Xenoport Inc |
Von aminosäuren abgeleitete prodrugs von propofolzusammensetzungen und anwendungen davon
|
|
US7241807B2
(en)
*
|
2004-07-12 |
2007-07-10 |
Xenoport, Inc. |
Prodrugs of propofol, compositions and uses thereof
|
|
US20060128676A1
(en)
*
|
2004-07-13 |
2006-06-15 |
Pharmacofore, Inc. |
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing diseases or pain
|
|
US7560544B2
(en)
|
2004-12-17 |
2009-07-14 |
Anadys Pharmaceuticals, Inc. |
3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
|
|
EP1844000B1
(de)
*
|
2004-12-23 |
2010-01-27 |
Xenoport, Inc. |
Von serinaminosäure abgeleitete prodrugs von propofol, zusammensetzungen, anwendungen und kristalline formen davon
|
|
WO2006084016A1
(en)
|
2005-02-01 |
2006-08-10 |
Attenuon, Llc |
ACID ADDITION SALTS OF Ac-PHSCN-NH2
|
|
US20070135380A1
(en)
|
2005-08-12 |
2007-06-14 |
Radiorx, Inc. |
O-nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
US7507842B2
(en)
|
2005-08-12 |
2009-03-24 |
Radiorx, Inc. |
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
US8163701B2
(en)
|
2005-08-19 |
2012-04-24 |
Signature Therapeutics, Inc. |
Prodrugs of active agents
|
|
US7524848B2
(en)
*
|
2006-03-23 |
2009-04-28 |
Amgen Inc. |
Diaza heterocyclic amide compounds and their uses
|
|
MX2008014794A
(es)
|
2006-05-26 |
2009-04-08 |
Pharmacofore Inc |
Liberacion controlada de opioides fenolicos.
|
|
TW200808695A
(en)
|
2006-06-08 |
2008-02-16 |
Amgen Inc |
Benzamide derivatives and uses related thereto
|
|
ATE476418T1
(de)
*
|
2006-06-08 |
2010-08-15 |
Amgen Inc |
Benzamidderivate und assoziierte verwendungen
|
|
KR101461604B1
(ko)
|
2006-06-22 |
2014-11-18 |
애나디스 파마슈티칼스, 인코포레이티드 |
5-아미노-3-(3''-데옥시-β-D-리보퓨라노실)-티아졸로[4,5-d]파이리미딘-2,7-다이온의 프로드럭
|
|
NZ573875A
(en)
|
2006-06-22 |
2011-11-25 |
Anadys Pharmaceuticals Inc |
Pyrro[1,2-b]pyridazinone compounds
|
|
WO2008011406A2
(en)
|
2006-07-18 |
2008-01-24 |
Anadys Pharmaceuticals, Inc. |
Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines
|
|
AU2007275301A1
(en)
*
|
2006-07-20 |
2008-01-24 |
Amgen Inc. |
Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1
|
|
US7673820B2
(en)
*
|
2006-12-18 |
2010-03-09 |
Yehuda Ivri |
Subminiature thermoelectric fragrance dispenser
|
|
CA2673586A1
(en)
*
|
2006-12-26 |
2008-07-24 |
Amgen Inc. |
N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
|
|
US9603848B2
(en)
*
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US20080306076A1
(en)
*
|
2007-06-08 |
2008-12-11 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US7928111B2
(en)
*
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
WO2009003061A1
(en)
|
2007-06-25 |
2008-12-31 |
Fred Hutchinson Cancer Research Center |
Methods and compositions regarding polychalcogenide compositions
|
|
HUE034563T2
(en)
|
2007-08-10 |
2018-02-28 |
Vm Discovery Inc |
Preparations and methods comprising apotheque modulators
|
|
ES2915065T3
(es)
|
2008-07-31 |
2022-06-20 |
Firmenich Incorporated |
Procedimientos para hacer potenciadores del sabor dulce
|
|
WO2010014813A2
(en)
|
2008-07-31 |
2010-02-04 |
Senomyx, Inc. |
Compositions comrpising sweetness enhancers and methods of making them
|
|
US20110229438A1
(en)
|
2008-10-09 |
2011-09-22 |
Anadys Pharmaceuticals, Inc. |
Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds
|
|
WO2010042925A2
(en)
|
2008-10-10 |
2010-04-15 |
Vm Discovery Inc. |
Compositions and methods for treating alcohol use disorders, pain and other diseases
|
|
JP5752601B2
(ja)
|
2008-12-08 |
2015-07-22 |
ブイエム ファーマ エルエルシー |
タンパク質受容体チロシンキナーゼ阻害薬の組成物
|
|
FR2950545B1
(fr)
*
|
2009-09-29 |
2012-11-30 |
Centre Nat Rech Scient |
Dispositif et procede de projection electrostatique d'un liquide, injecteur de carburant incorporant ce dispositif et utilisations de ce dernier
|
|
US8471041B2
(en)
*
|
2010-02-09 |
2013-06-25 |
Alliant Techsystems Inc. |
Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
|
|
WO2012021837A2
(en)
|
2010-08-12 |
2012-02-16 |
Senomyx, Inc. |
Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer
|
|
WO2012109363A2
(en)
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
US20120321590A1
(en)
|
2011-04-06 |
2012-12-20 |
Anadys Pharmaceuticals, Inc. |
Bridged polycyclic compounds
|
|
US8664247B2
(en)
|
2011-08-26 |
2014-03-04 |
Radiorx, Inc. |
Acyclic organonitro compounds for use in treating cancer
|
|
US9139519B2
(en)
|
2011-10-07 |
2015-09-22 |
Epicentrx, Inc. |
Organonitro thioether compounds and medical uses thereof
|
|
US20140308260A1
(en)
|
2011-10-07 |
2014-10-16 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
|
US8586527B2
(en)
|
2011-10-20 |
2013-11-19 |
Jaipal Singh |
Cerivastatin to treat pulmonary disorders
|
|
BR112014014262A2
(pt)
|
2011-12-14 |
2017-06-13 |
Univ Johns Hopkins |
nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas.
|
|
EP3409666A3
(de)
|
2012-06-07 |
2019-01-02 |
Georgia State University Research Foundation, Inc. |
Seca-hemmer und verfahren zur herstellung und verwendung davon
|
|
BR112015002380B1
(pt)
|
2012-08-06 |
2021-09-28 |
Firmenich Incorporated |
Composto, composições ingeríveis, processos para aumentar o sabor doce de composição e formulação flavorizante concentrada
|
|
RS58010B1
(sr)
|
2012-09-27 |
2019-02-28 |
Childrens Medical Ct Corp |
Jedinjenja za lečenje gojaznosti i postupci za njihovu upotrebu
|
|
JO3155B1
(ar)
|
2013-02-19 |
2017-09-20 |
Senomyx Inc |
معدِّل نكهة حلوة
|
|
PT3074033T
(pt)
|
2013-11-26 |
2019-02-08 |
Childrens Medical Ct Corp |
Compostos para o tratamento de obesidade e métodos de utilização dos mesmos
|
|
KR101723997B1
(ko)
|
2014-02-05 |
2017-04-06 |
브이엠 온콜로지 엘엘씨 |
화합물의 조성물 및 이의 용도
|
|
US20170209408A1
(en)
|
2014-04-03 |
2017-07-27 |
The Children's Medical Center Corporation |
Hsp90 inhibitors for the treatment of obesity and methods of use thereof
|
|
US10335406B2
(en)
|
2015-10-01 |
2019-07-02 |
Elysium Therapeutics, Inc. |
Opioid compositions resistant to overdose and abuse
|
|
AU2016332071B2
(en)
|
2015-10-01 |
2019-04-18 |
Elysium Therapeutics, Inc. |
Polysubunit opioid prodrugs resistant to overdose and abuse
|
|
US10342778B1
(en)
|
2015-10-20 |
2019-07-09 |
Epicentrx, Inc. |
Treatment of brain metastases using organonitro compound combination therapy
|
|
US9987270B1
(en)
|
2015-10-29 |
2018-06-05 |
Epicentrix, Inc. |
Treatment of gliomas using organonitro compound combination therapy
|
|
CN109069420A
(zh)
|
2016-01-11 |
2018-12-21 |
埃皮辛特瑞柯斯公司 |
2-溴-1-(3,3-二硝基氮杂环丁烷-1-基)乙酮静脉施用的组合物和方法
|
|
CN110352190A
(zh)
|
2016-10-14 |
2019-10-18 |
埃皮辛特瑞柯斯公司 |
用于医疗用途的磺氧基烷基有机硝基和相关化合物和药物组合物
|
|
EP3595663A4
(de)
|
2017-03-17 |
2021-01-13 |
Elysium Therapeutics, Inc. |
Mehrfachuntereinheit-opioid-prodrugs mit resistenz gegen überdosierung und missbrauch
|
|
US11744859B2
(en)
|
2017-07-07 |
2023-09-05 |
Epicentrx, Inc. |
Compositions and methods for parenteral administration of therapeutic agents
|
|
US11510901B2
(en)
|
2018-01-08 |
2022-11-29 |
Epicentrx, Inc. |
Methods and compositions utilizing RRx-001 combination therapy for radioprotection
|
|
WO2019200274A1
(en)
|
2018-04-12 |
2019-10-17 |
MatRx Therapeutics Corporation |
Compositions and methods for treating elastic fiber breakdown
|
|
BR112021002261A2
(pt)
|
2018-08-07 |
2021-05-04 |
Firmenich Incorporated |
2,2-dióxidos de 4-amino-1h-benzo[c][1,2,6]tiadiazina 5-substituídos e formulações e usos dos mesmos
|
|
SG11202112717YA
(en)
|
2019-05-17 |
2021-12-30 |
Aether Inc |
Device and method for managing fine particle concentration
|
|
US12211684B2
(en)
|
2019-10-31 |
2025-01-28 |
New Objective, Inc. |
Method and device for improved performance with micro-electrospray ionization
|
|
US11980907B2
(en)
|
2021-05-20 |
2024-05-14 |
Climb Works LLC |
Electrostatic sprayer
|
|
CN114308433B
(zh)
*
|
2021-12-20 |
2024-01-05 |
江苏大学 |
一种气力辅助静电喷头
|
|
WO2023178283A1
(en)
|
2022-03-18 |
2023-09-21 |
Epicentrx, Inc. |
Co-crystals of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone and methods
|
|
WO2023215229A1
(en)
|
2022-05-02 |
2023-11-09 |
Epicentrx, Inc. |
Compositions and methods for treatment of pulmonary hypertension
|
|
WO2023215227A1
(en)
|
2022-05-02 |
2023-11-09 |
Epicentrx, Inc. |
Systems and methods to improve exercise tolerance
|
|
EP4536222A1
(de)
|
2022-06-13 |
2025-04-16 |
EpicentRx, Inc. |
Zusammensetzungen und verfahren zur verringerung unerwünschter nebenwirkungen bei der krebsbehandlung
|
|
WO2024098009A1
(en)
|
2022-11-04 |
2024-05-10 |
Epicentrx, Inc. |
Rrx-001 for minimizing post-infarct adverse ventricular remodeling and complications
|
|
WO2024124152A1
(en)
|
2022-12-08 |
2024-06-13 |
Epicentrx, Inc. |
Rrx-001 for the treatment of a hemoglobinopathy
|